CA

Cardinal Health, Inc.

CAHHealthcareNASDAQ

Medical Distribution

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$254.25B
+14.2% YoY
Net Income
$1.71B
+9.8% YoY
EBITDA
$3.48B
+12.0% YoY
Free Cash Flow
$4.75B

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 MACD Positive CrossoverHistogram +0.6223, positive momentum
Sep 2 MACD Positive CrossoverHistogram +0.0717, positive momentum
About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. At a $57.49B market cap, Cardinal Health, Inc. ranks as a large-cap company within healthcare. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.

Where CAH stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, CAH finished 12.60% above its 150-day moving average ($218.02) and 14.36% above its 200-day moving average ($214.66). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CAH overbought or oversold?

At the September 3, 2026 close, CAH's RSI(14) was 69.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$57.49B
P/E (TTM)34.24
Fwd P/E17.56
EPS$7.22
Beta0.52
52W Change+63.8%
Dividend Yield0.83%
Analysis

Cardinal Health, Inc. carries $10.00B in total debt against $4.86B in cash reserves — debt is roughly 2.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $4.75B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROA of 3.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $204.98B (2023) to $254.25B (2026), reflecting a 24% increase over the period.

The relatively low beta of 0.52 suggests CAH is a less volatile holding compared to the broader index. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Cardinal Health, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms